α1-Antitrypsin deficiency • 3: Clinical manifestations and natural history

A review of the clinical manifestations of α1-antitrypsin (AAT) deficiency, including lung disease and liver disease, and risk factors affecting the rate of decline in lung function in AAT deficient patients.

[1]  M. Schwartz,et al.  β1-Antitrypsin deficiency and chronic pancreatitis , 1995, Digestive Diseases and Sciences.

[2]  R. Pauwels,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003 , 2004, COPD.

[3]  V. Grassi,et al.  Airway hyperresponsiveness in a large group of subjects with α1‐antitrypsin deficiency: a cross‐sectional controlled study , 2003, Journal of internal medicine.

[4]  A. Buist,et al.  Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. , 2003, Chest.

[5]  B. Nordestgaard,et al.  Blood Pressure, Risk of Ischemic Cerebrovascular and Ischemic Heart Disease, and Longevity in &agr;1-Antitrypsin Deficiency: The Copenhagen City Heart Study , 2003, Circulation.

[6]  J. Morris,et al.  Severe panniculitis caused by homozygous ZZ α1‐antitrypsin deficiency treated successfully with human purified enzyme (Prolastin®) , 2002, The British journal of dermatology.

[7]  R. Stockley,et al.  The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ). , 2002, Chest.

[8]  E. Piitulainen,et al.  Respiratory symptoms and lung function in young adults with severe α1–antitrypsin deficiency (PiZZ) , 2002, Thorax.

[9]  R. Stockley,et al.  The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. , 2002, American journal of respiratory and critical care medicine.

[10]  A. Kage,et al.  α 1 -Antitrypsin Genotypes in Patients with Chronic Pancreatitis , 2002 .

[11]  A. Kage,et al.  Alpha1-antitrypsin genotypes in patients with chronic pancreatitis. , 2002, Scandinavian journal of gastroenterology.

[12]  L. Pini,et al.  Alpha-1-Antitrypsin Deficiency and Nephropathy , 2001, Nephron.

[13]  R. Stockley,et al.  Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. , 2001, American journal of respiratory and critical care medicine.

[14]  J. Finsterer,et al.  Nail-Patella Syndrome Associated with Respiratory Chain Disorder , 2001, European Neurology.

[15]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[16]  A. Testa,et al.  Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  J. Lieberman.  Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. , 2000, Chest.

[18]  J. Wilson,et al.  Normal diffusing capacity in patients with PiZ alpha(1)-antitrypsin deficiency, severe airflow obstruction, and significant radiographic emphysema. , 2000, Chest.

[19]  J. Stoller,et al.  Occupational Exposure Risks in Individuals with PI*Z α1-Antitrypsin Deficiency , 2000 .

[20]  R. Stockley,et al.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care , 2000, Thorax.

[21]  J. Benichou,et al.  Distribution of α1-Antitrypsin alleles in patients with Bronchiectasis , 2000 .

[22]  J. Benichou,et al.  Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. , 2000, Chest.

[23]  J. Stoller,et al.  Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. , 2000, American journal of respiratory and critical care medicine.

[24]  R. Stockley,et al.  Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). , 1999, American journal of respiratory and critical care medicine.

[25]  E. Piitulainen,et al.  Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). , 1999, The European respiratory journal.

[26]  E. Piitulainen,et al.  Environmental correlates of impaired lung function in non-smokers with severe α1-antitrypsin deficiency (PiZZ) , 1998, Thorax.

[27]  E. Piitulainen,et al.  Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with α1‐antitrypsin deficiency , 1998, Acta paediatrica.

[28]  W. Balistreri.  Transplantation for childhood liver disease: an overview. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  H. Fischer,et al.  Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. , 1998, The American journal of surgical pathology.

[30]  R. S. Sen,et al.  Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin , 1998 .

[31]  Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. , 1998, American journal of respiratory and critical care medicine.

[32]  S. Eriksson,et al.  Alpha 1-antitrypsin deficiency. , 1998, Bailliere's clinical gastroenterology.

[33]  F. Callea,et al.  α1‐Antitrypsin (AAT) deficiency and ANCA‐positive systemic vasculitis: genetic and clinical implications , 1997 .

[34]  B. Veress,et al.  Severe α1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation , 1997 .

[35]  E. Piitulainen,et al.  Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). , 1997, Thorax.

[36]  M. Schluchter,et al.  Baseline Characteristics of Enrollees in the National Heart, Lung and Blood Institute Registry of α1-Antitrypsin Deficiency , 1997 .

[37]  M. Schluchter,et al.  Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. , 1997, Chest.

[38]  F. Callea,et al.  alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications. , 1997, European journal of clinical investigation.

[39]  B. Veress,et al.  Severe alpha1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation. , 1997, Journal of hepatology.

[40]  S. Eriksson,et al.  Risk of hepatobiliary disease in adults with severe α1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? , 1996, European journal of gastroenterology & hepatology.

[41]  D. Steed,et al.  Alpha-1-antitrypsin deficiency in aneurysmal disease. , 1996, Human heredity.

[42]  A. Dirksen,et al.  Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. , 1995, American journal of respiratory and critical care medicine.

[43]  Kristina J. Liu,et al.  Report of two cases , 1995 .

[44]  T. Sveger,et al.  Other clinical studyThe liver in adolescents with α1-antitrypsin deficiency☆ , 1995 .

[45]  T. Sveger,et al.  The liver in adolescents with α‐antitrypsin deficiency , 1995 .

[46]  J. Savige,et al.  α1‐Antitrypsin deficiency and anti‐proteinase 3 antibodies in anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis , 1995, Clinical and experimental immunology.

[47]  T. Sveger,et al.  The liver in adolescents with alpha 1-antitrypsin deficiency. , 1995, Hepatology.

[48]  M. Schwartz,et al.  Alpha 1-antitrypsin deficiency and chronic pancreatitis. , 1995, Digestive diseases and sciences.

[49]  W. Vogel,et al.  Alpha 1-antitrypsin phenotypes in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis. , 1994, Clinical science.

[50]  J. Stoller,et al.  Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. , 1994, Cleveland Clinic journal of medicine.

[51]  S. Eriksson,et al.  Strong link between the alpha1‐antitrypsin PiZ allele and Wegener's granulomatosis , 1994, Journal of internal medicine.

[52]  Traulsen Jb.  [Panniculitis associated with severe alpha 1-antitrypsin deficiency]. , 1994 .

[53]  K. Ho,et al.  Bronchiectasis in Patients With α1-Antitrypsin Deficiency : A Rare Occurrence? , 1993 .

[54]  Jean‐Pierre Martin,et al.  Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. , 1993, Kidney international.

[55]  K. Ho,et al.  Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence? , 1993, Chest.

[56]  D. Hansell,et al.  High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. , 1992, Clinical radiology.

[57]  E. Jaurrieta,et al.  Combined liver-kidney transplantation. , 1992, Transplantation Proceedings.

[58]  B. Burke,et al.  The pathologic spectrum of the nephropathy associated with α1-antitrypsin deficiency , 1992 .

[59]  B. Burke,et al.  The pathologic spectrum of the nephropathy associated with alpha 1-antitrypsin deficiency. , 1992, Human pathology.

[60]  J. Hodge,et al.  Alpha1‐Antitrypsin Deficiency‐Associated Panniculitis: Case Report and Review of the Literature , 1991, Pediatric dermatology.

[61]  M. Wilkinson,et al.  Alpha 1-antitrypsin deficiency and pancreatitis in a juvenile. , 1991, Australian and New Zealand journal of medicine.

[62]  J. Hodge,et al.  Alpha 1-antitrypsin deficiency-associated panniculitis: case report and review of the literature. , 1991, Pediatric dermatology.

[63]  P. Agache,et al.  Use of anti-collagenase properties of doxycycline in treatment of alpha 1-antitrypsin deficiency panniculitis. , 1991, Acta dermato-venereologica.

[64]  C. Gross,et al.  Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. , 1990, The Journal of pediatrics.

[65]  E. Silverman,et al.  A family study of the variability of pulmonary function in α1-antitrypsin deficiency: Quantitative phenotypes , 1990 .

[66]  E. Silverman,et al.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus. , 1990, Human heredity.

[67]  E. Silverman,et al.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. , 1989, Annals of internal medicine.

[68]  Kevin C. Smith,et al.  Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of α1-antitrypsin , 1989 .

[69]  J. Pierce,et al.  Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease. , 1989, The Journal of clinical investigation.

[70]  R. Winkelmann,et al.  Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of alpha 1-antitrypsin. , 1989, Journal of the American Academy of Dermatology.

[71]  T. Sveger.  The Natural History of Liver Disease in (α1‐Antitrypsin Deficient Children , 1988 .

[72]  T. Sveger.  The natural history of liver disease in alpha 1-antitrypsin deficient children. , 1988, Acta paediatrica Scandinavica.

[73]  M. Pittelkow,et al.  Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature. , 1987, Archives of dermatology.

[74]  R. Winkelmann,et al.  Alpha 1-antitrypsin deficiency panniculitis: a histopathologic and immunopathologic study of four cases. , 1987, The American Journal of dermatopathology.

[75]  J. Carlson,et al.  Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. , 1986, The New England journal of medicine.

[76]  J. Wright,et al.  Liver disease in alpha 1-antitrypsin deficiency. A retrospective analysis of the influence of early breast- vs bottle-feeding. , 1985, JAMA.

[77]  R. Carrell,et al.  SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCY , 1985, The Lancet.

[78]  M. Tobin,et al.  Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. , 1983, British journal of diseases of the chest.

[79]  A. J. Mcadams,et al.  Membranoproliferative glomerulonephritis and alpha 1-antitrypsin deficiency in children. , 1983, Pediatrics.

[80]  M. Tobin,et al.  Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. , 1983, British journal of diseases of the chest.

[81]  J. Versieck,et al.  Alphai-Antitrypsin in Pancreatitis , 1982 .

[82]  J. Versieck,et al.  Alpha 1-antitrypsin in pancreatitis. , 1982, Digestion.

[83]  A. J. Chandrasekhar,et al.  Alpha1-antitrypsin deficiency with severe panniculitis. Report of two cases. , 1977, Annals of internal medicine.

[84]  T Sveger,et al.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. , 1976, The New England journal of medicine.

[85]  J. Balfe,et al.  Membranoproliferative glomerulonephritis in childhood cirrhosis associated with alpha1-antitrypsin deficiency. , 1976, Pediatrics.

[86]  I. Marks,et al.  CHRONIC PANCREATITIS AND ALPHA-1-ANTITRYPSIN , 1975, The Lancet.

[87]  W. F. Miller,et al.  Pulmonary emphysema and alpha 1-antitrypsin deficiency. , 1968, The American journal of medicine.

[88]  Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. , 1965, Lancet.